Brief: Bellicum Pharma Qtrly Loss Per Share $0.55
06/11/2018 21:24
Nov 6 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.55
* Q3 EARNINGS PER SHARE VIEW $-0.58 -- THOMSON REUTERS
I/B/E/S
Source text for Eikon: ID:nGNX6CtFJz
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview